Skip to main content
Equibles
ETON logo

ETON · Eton Pharmaceuticals, Inc. · Metrics

Track ETON — free

Use ETON with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ETON.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$57.08 -0.80 (-1.38%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$1.63B
Shares
28.58M

ETON metrics

80 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$57.08
Market cap
$1.63B

Price action

20 metrics
Price change (1W)
-2.3%
Price change (30D)
+39.9%
Price change (3M)
+80.7%
Price change (6M)
+201.5%
Price change (YTD)
+237.6%
Price change (1Y)
+224.9%
Trailing year
Price change (5Y)
+1,039.3%
52-week high
$64.43
52-week low
$14.35
Change from 52-week high
-11.4%
Change from 52-week low
+297.8%
Annualized volatility
70.9%
Annualized volatility (3M)
102.1%
Beta
0.1
RSI (14D)
52.6
Price vs SMA 50
+15.3%
Price vs SMA 200
+96.1%
Avg volume (3M)
551,558
Relative volume
0.6
Average dollar volume
$26.59M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
28.58M

Valuation

12 metrics
P / E (TTM)
128.6
Trailing earnings · reciprocal yield 0.8%
PEG ratio
—
EV / revenue
15.5×
reciprocal yield 6.5%
EV / EBITDA
78.3×
reciprocal yield 1.3%
EV / EBIT
100.1×
reciprocal yield 1.0%
P / sales
15.5×
reciprocal yield 6.5%
P / book
35.0
reciprocal yield 2.9%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
107.8
reciprocal yield 0.9%
Earnings yield
0.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
6.6×
reciprocal yield 15.2%
EV / revenue historical average (5Y)
5.5×
reciprocal yield 18.0%
EV / EBIT historical average (3Y)
163.9×
reciprocal yield 0.6%
EV / EBIT historical average (5Y)
163.9×
reciprocal yield 0.6%
EV / EBITDA historical average (3Y)
202.7×
reciprocal yield 0.5%
EV / EBITDA historical average (5Y)
193.4×
reciprocal yield 0.5%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
57.9%
Operating margin
15.4%
Trailing 12 months
Net margin
12.0%
Gross profit (TTM)
$61.10M
Operating profit (TTM)
$16.31M
Net income (TTM)
$12.69M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
0.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.97

Growth

11 metrics
Revenue growth YoY
+98.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$105.59M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+21.9%
Year over year · more shares
Revenue CAGR (3Y)
+55.5%
Revenue CAGR (5Y)
+359.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+28.7%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
27.2%
Return on assets
11.0%
Debt / equity
0.6
Current ratio
1.5
EBITDA (TTM)
$20.85M
Free cash flow (TTM)
—
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
0.1
Return on invested capital
34.1%
Trailing 12 months
Net cash
−$1.06M
Latest balance sheet
Cash & equivalents
$26.84M
Total assets
$115.81M
Total debt
$27.90M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$15.13M
Capital expenditures (TTM)
$403,000
R&D (TTM)
$5.76M
SG&A (TTM)
—
Stock compensation (TTM)
$5.20M
R&D / revenue
5.5%
Stock compensation / revenue
4.9%

Ownership (13F)

3 metrics
13F filers
163
13F filer change QoQ
+47
Institutional ownership
70.5%

Short interest

3 metrics
Short interest
4.7%
Latest settlement · 2.0 days to cover
Days to cover
2.0d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$18.12M
Insider-sentiment score
6 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1710340 CUSIP 29772L108 13F (30d) 83 filings 83 filers Visit website Investor relations